Description Data Bridge Market Research analyses that the molecular diagnostics market, which was USD 20.1 billion in 2022, would rise to USD 54.76 billion by 2030 and is expected to undergo a CAGR of 13.3% during the forecast period from 2023 to 203...
research the future
NULISA is an ultra-sensitive, high-throughput proteomics platform from Alamar Biosciences designed for biomarker detection across alternative sample types with attomolar sensitivity and a 12-log dynamic range.
Markdown supported · ⌘↵ to post
No responses yet.